Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug. [Source]
Publication Date:Origin: nytimes.com
Category: Mergers, Acquisitions and Divestitures
Topics: Lilly, trial, clinical, midstage, conducting, which, Pharmaceuticals, Centessa, acquire, plans, Billion, Developer, Narcolepsy
Source: https://www.nytimes.com/2026/03/31/business/eli-lilly-narcolepsy-centessa.html